Greenwich LifeSciences, Inc. (GLSI)
15.90
-0.05
(-0.31%)
USD |
NASDAQ |
Sep 08, 16:00
15.67
-0.23
(-1.45%)
Pre-Market: 20:00
Greenwich LifeSciences Market Cap : 233.38M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 233.38M |
| September 04, 2026 | 234.12M |
| September 03, 2026 | 229.42M |
| September 02, 2026 | 231.03M |
| September 01, 2026 | 220.32M |
| August 31, 2026 | 219.44M |
| August 28, 2026 | 230.01M |
| August 27, 2026 | 274.92M |
| August 26, 2026 | 267.58M |
| August 25, 2026 | 272.87M |
| August 24, 2026 | 258.04M |
| August 21, 2026 | 244.69M |
| August 20, 2026 | 224.72M |
| August 19, 2026 | 254.52M |
| August 18, 2026 | 253.35M |
| August 17, 2026 | 255.11M |
| August 14, 2026 | 246.59M |
| August 13, 2026 | 240.43M |
| August 12, 2026 | 248.36M |
| August 11, 2026 | 228.25M |
| August 10, 2026 | 227.51M |
| August 07, 2026 | 210.78M |
| August 06, 2026 | 208.84M |
| August 05, 2026 | 211.04M |
| August 04, 2026 | 210.46M |
| Date | Value |
|---|---|
| August 03, 2026 | 198.58M |
| July 31, 2026 | 197.99M |
| July 30, 2026 | 205.62M |
| July 29, 2026 | 187.72M |
| July 28, 2026 | 197.26M |
| July 27, 2026 | 197.11M |
| July 24, 2026 | 190.36M |
| July 23, 2026 | 193.44M |
| July 22, 2026 | 194.62M |
| July 21, 2026 | 214.86M |
| July 20, 2026 | 206.35M |
| July 17, 2026 | 239.35M |
| July 16, 2026 | 278.80M |
| July 15, 2026 | 286.57M |
| July 14, 2026 | 278.80M |
| July 13, 2026 | 272.35M |
| July 10, 2026 | 290.39M |
| July 09, 2026 | 287.01M |
| July 08, 2026 | 276.75M |
| July 07, 2026 | 272.35M |
| July 06, 2026 | 299.77M |
| July 02, 2026 | 322.65M |
| July 01, 2026 | 347.58M |
| June 30, 2026 | 344.06M |
| June 29, 2026 | 340.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| PEG Ratio | -0.6389 |
| Price to Book Value | 74.88 |
| Price | 15.90 |
| Earnings Yield | -9.54% |
| PEGY Ratio | -0.6389 |